RYPLAZIM Trademark

Trademark Overview

On Friday, November 25, 2016, a trademark application was filed for RYPLAZIM with the United States Patent and Trademark Office. The USPTO has given the RYPLAZIM trademark a serial number of 87247928. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, March 10, 2026. This trademark is owned by ProMetic BioTherapeutics, Inc.. The RYPLAZIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies

General Information

Serial Number87247928
Word MarkRYPLAZIM
Filing DateFriday, November 25, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, March 10, 2026
Registration Number5929628
Registration DateTuesday, December 10, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 1, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKEDRION BIOPHARMA INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFORT LEE, NJ 07024
US
Party NameProMetic BioTherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
US
Party NameProMetic BioTherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
US
Party NameProMetic BioTherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
US

Trademark Events

Event DateEvent Description
Tuesday, November 29, 2016NEW APPLICATION ENTERED
Thursday, December 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 1, 2017ASSIGNED TO EXAMINER
Friday, March 3, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, March 3, 2017EXAMINERS AMENDMENT E-MAILED
Friday, March 3, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 3, 2017EXAMINER'S AMENDMENT ENTERED
Friday, March 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 11, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, October 11, 2017SOU EXTENSION 1 FILED
Wednesday, October 11, 2017SOU EXTENSION 1 GRANTED
Friday, October 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 9, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, May 9, 2018SOU EXTENSION 2 FILED
Wednesday, May 9, 2018SOU EXTENSION 2 GRANTED
Friday, May 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 12, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018SOU EXTENSION 3 FILED
Wednesday, December 12, 2018SOU EXTENSION 3 GRANTED
Friday, December 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019SOU TEAS EXTENSION RECEIVED
Monday, June 3, 2019SOU EXTENSION 4 FILED
Monday, June 3, 2019SOU EXTENSION 4 GRANTED
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2019TEAS PETITION TO AMEND BASIS RECEIVED
Friday, August 9, 2019ASSIGNED TO PETITION STAFF
Friday, August 9, 2019PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Friday, August 16, 2019NOTICE OF ALLOWANCE CANCELLED
Wednesday, September 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 24, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 29, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 6, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 10, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 8, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, March 9, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 10, 2026REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, March 10, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

ryplazim plasminogen deficiencies associated conditions preparations treatment pharmaceutical